About Us

You are here:
  1. Home
  2. About Us

QUEST MEDICAL SERVING CARDIOLOGY, INFUSION THERAPY, AND OPHTHALMOLOGY

1

 

Quest Medical was founded on the premise of developing medical devices that would have a positive impact on patient care. Since 1979, we have been dedicated to providing the highest quality products to our 3 focused markets: Cardiology, Infusion Therapy, and Ophthalmology.

OUR EVOLVING PRODUCT LINES – MPS AND INFUSION THERAPY

The Myocardial Protection System (MPS) was first released in 1996. The MPS is used during an open-heart operation allowing a surgeon to utilize an all-blood cardioplegia versus other cardioplegia strategies that dilute the blood, however the MPS can be used with any cardioplegia strategy. The MPS allows greater control, utilizes enhanced safety features along with precise, adjustable delivery of cardioprotective drugs to the patient. The second generation, MPS 2, was released in 2004 and has successfully been used in U.S. and international markets. The latest generation, MPS® 3 System, offers even more control to perfusionists and surgeons than previous models. The new MPS® 3 System features now incorporate a touch screen interface with several new capabilities and precision control. Both the MPS® 3 and MPS 3 ND Systems are available in the USA and Canada.

Quest has been active in the infusion therapy market since the founding of the company. As a strong supporter of a no-needles approach to fluid delivery, Quest developed capped luer lock ports on early manifolds and IV sets. With continued development, Quest has evolved the product lines with the use of swabable, needleless, valve technology – Q2® split septum technology. The Q2 technology has been incorporated into many products, some will have check valves to ensure of a one-way flow of fluids and protect from retrograde flow.

…QUEST HAS EVOLVED THE PRODUCT LINES WITH THE USE OF SWABABLE, NEEDLELESS, VALVE TECHNOLOGY – Q2® SPLIT SEPTUM TECHNOLOGY.

OUR CORE BELIEFS

EMPOWERMENT

BE BOLD. BE DECISIVE. BE THE CHANGE THAT CREATES MAXIMUM IMPACT AND SUCCESS THROUGH ACCOUNTABILITY, SERVICE AND QUALITY

SPEED & PURPOSE

MOVE FAST. SEIZE OPPORTUNITY. EMBRACE AN AGILE MINDSET THAT TRANSLATES VALUE INTO THE MOST DIRECT PATH TO ACHIEVING PURPOSEFUL RESULTS

INNOVATION

BRING IDEAS TO LIFE. BIG OR SMALL, INCREMENTAL OR RADICAL, WE DELIVER HIGH QUALITY SOLUTIONS THAT SERVE PEOPLE IN IMPACTFUL AND MEANINGFUL WAYS

1979 Quest Founded
Quest was founded with the intention to produce better volumetric pump.
1991 Quest Acquisition
Quest acquired Heathdyne and American Omni and entered the market of Perfusion Safety.
1996 Change and Growth
Generation 1 of the Quest MPS® System is introduced to the market. - Sold Volumetric Pumps - Quest acquired by Atrion, added Ophthalmology to catalog.
2004 MPS® Technology
2nd generation of the Quest MPS® System is introduced to market.
2008 Q2® Technology
Quest expanded the development of our swabable valve technology.
2020 Cardiovascular Advancements
Generation 3 of the Quest MPS® System is released. Quest Named Top Workplace in DFW. - Develops Program Introduced
2021 IVT Expansion
- IVT Catalog Expansion +88 SKUs - Quest MPS®3 ND System is released to Market - Quest Named Top Workplace in DFW
2022+ Quest’s Future
Quest’s NPD Program has created a pipeline of innovative product offerings that will solve clinician concerns for years to come.